Hisashi Doi

Find an error

Name:
Organization: RIKEN Center for Molecular Imaging Science (CMIS) , Japan
Department: Molecular Probe Dynamics Laboratory
Title: (PhD)

TOPICS

Co-reporter:Hisashi Doi, Kengo Sato, Hideo Shindou, Kengo Sumi, Hiroko Koyama, Takamitsu Hosoya, Yasuyoshi Watanabe, Satoshi Ishii, Hideo Tsukada, Koji Nakanishi, Masaaki Suzuki
Bioorganic & Medicinal Chemistry 2016 Volume 24(Issue 21) pp:5148-5157
Publication Date(Web):1 November 2016
DOI:10.1016/j.bmc.2016.08.032
The blood–brain barrier permeability of ginkgolide B was examined using positron emission tomography (PET) probes of a 18F-incorporated ginkgolide B ([18F]-2) and a 11C-incorporated methylbenzyl-substituted ginkgolide B ([11C]-3). PET studies in monkeys showed low uptake of [18F]-2 into the brain, but small amounts of [11C]-3 were accumulated in the parenchyma. Furthermore, when cyclosporine A was preadministered to rats, the accumulation of [18F]-2 in the rat brain did not significantly change, however, the accumulation of [11C]-3 was five times higher than that in the control rat. These results provide effective approaches for investigating the drug potential of ginkgolides.
Co-reporter:Hisashi Doi
Journal of Labelled Compounds and Radiopharmaceuticals 2015 Volume 58( Issue 3) pp:73-85
Publication Date(Web):
DOI:10.1002/jlcr.3253

Prof. Bengt Långström is a pioneer in the field of chemistry-driven positron emission tomography (PET) imaging. He has developed a variety of excellent radiolabeling methodologies using the methods of organic chemistry, with the aim of widening the potential of PET in the study of life. Among his groundbreaking achievements in 11C radiochemistry, there is the discovery of the Pd-mediated rapid cross-coupling reaction using [11C]methyl iodide. It was first reported by his Uppsala group in 1994–1995 and was further investigated by his and other groups with a view of enhancing its generality and practicability. This reaction is currently considered one of the basic methods for 11C-labeling of low-weight organic compounds. This paper presents a short summary of the background and the development of Pd-mediated rapid cross-couplings of [11C]methyl iodide, with a focus not only on organostannanes, but also on organoboranes, organozincs, and terminal acetylene compounds. All these reactions have proven to be dependable 11C-labeling methodologies that use chemically reliable carbon–carbon bond formation reactions.

Co-reporter:Keiji Yashio, Yumiko Katayama, Tadayuki Takashima, Naoki Ishiguro, Hisashi Doi, Masaaki Suzuki, Yasuhiro Wada, Ikumi Tamai, Yasuyoshi Watanabe
Bioorganic & Medicinal Chemistry Letters 2012 Volume 22(Issue 1) pp:115-119
Publication Date(Web):1 January 2012
DOI:10.1016/j.bmcl.2011.11.055
The synthesis and in vivo evaluation of 11C -labeled uric acid ([11C]1), a potential imaging agent for the diagnosis of urate-related life-style diseases, was performed using positron emission tomography (PET) image analysis. First, the synthesis of [11C]1 was achieved by reacting 5,6-diaminouracil (2) with 11C-labeled phosgene ([11C]COCl2). The radiochemical yield of [11C]1 was 37 ± 7% (decay-corrected based on [11C]COCl2) with specific radioactivities of 96–152 GBq/μmol at the end of synthesis (n = 6). The average time of radiosynthesis from the end of bombardment, including formulation, was about 30 min with >98% radiochemical purity. Second, the synthetic approach to [11C]1 was optimized using 5,6-diaminouracil sulfate (3) with [11C]COCl2 in the presence of 1,8-bis(dimethylamino)naphthalene. [11C]1 was synthesized in 36 ± 6% radiochemical yield, 89–142 GBq/μmol of specific radioactivities, and 98% radiochemical purity by this method (n = 5). This allowed the synthesis of [11C]1 to be carried out repeatedly and the radiochemical yield, specific radioactivities, average time of synthesis, and radiochemical purity of [11C]1 were similar to those obtained using 2. PET studies in rats showed large differences in the accumulation of radioligand in the limbs under normal and hyperuricemic conditions. Thus, an efficient and convenient automated synthesis of [11C]1 has been developed, and preliminary PET evaluation of [11C]1 confirmed the increased accumulation of radioactivity in the limbs of a rat model of hyperuricemia.
3,6,7-Benzofurantriol triacetate
Silane, (2-bromoethoxy)(1,1-dimethylethyl)diphenyl-
(S)-6-((4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl)-1-methyl-1H-benzo[d][1,2,3]triazole
Benzodiazepine
SODIUM;2-METHANIDYLOXOLANE;SULFUROTHIOIC O-ACID
Carbon, isotope of mass11
Uridine, 2',3'-didehydro-2',3'-dideoxy-5-(tributylstannyl)-
Fursutiamine
1-[(2R,4S,5R)-5-[[TERT-BUTYL(DIMETHYL)SILYL]OXYMETHYL]-4-HYDROXYOXOLAN-2-YL]-5-IODOPYRIMIDINE-2,4-DIONE
5-(Bromomethyl)-2-methylpyrimidin-4-amine hydrobromide